Unraveling the risk factors for spontaneous intracerebral hemorrhage among West Africans
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective To characterize risk factors for spontaneous intracerebral hemorrhage (sICH) occurrence and severity among West Africans.
Methods The Stroke Investigative Research and Educational Network (SIREN) study is a multicenter case-control study involving 15 sites in Ghana and Nigeria. Patients were adults ≥18 years old with CT-confirmed sICH with age-, sex-, and ethnicity-matched stroke-free community controls. Standard instruments were used to assess vascular, lifestyle, and psychosocial factors. Factors associated with sICH and its severity were assessed using conditional logistic regression to estimate odds ratios (ORs) and population-attributable risks (PARs) with 95% confidence intervals (CIs) for factors.
Results Of 2,944 adjudicated stroke cases, 854 were intracerebral hemorrhage (ICH). Mean age of patients with ICH was 54.7 ± 13.9 years, with a male preponderance (63.1%), and 77.3% were nonlobar. Etiologic subtypes of sICH included hypertension (80.9%), structural vascular anomalies (4.0%), cerebral amyloid angiopathy (0.7%), systemic illnesses (0.5%), medication-related (0.4%), and undetermined (13.7%). Eight factors independently associated with sICH occurrence by decreasing order of PAR with their adjusted OR (95% CI) were hypertension, 66.63 (20.78–213.72); dyslipidemia, 2.95 (1.84–4.74); meat consumption, 1.55 (1.01–2.38); family history of CVD, 2.22 (1.41–3.50); nonconsumption of green vegetables, 3.61 (2.07–6.31); diabetes mellitus, 2.11 (1.29–3.46); stress, 1.68 (1.03–2.77); and current tobacco use, 14.27 (2.09–97.47). Factors associated with severe sICH using an NIH Stroke Scale score >15 with adjusted OR (95% CI) were nonconsumption of leafy green vegetables, 2.03 (1.43–2.88); systolic blood pressure for each mm Hg rise, 1.01 (1.00–1.01); presence of midline shift, 1.54 (1.11–2.13); lobar ICH, 1.72 (1.16–2.55); and supratentorial bleeds, 2.17 (1.06–4.46).
Conclusions Population-level control of the dominant factors will substantially mitigate the burden of sICH in West Africa.
Glossary
- aOR=
- adjusted odds ratio;
- BP=
- blood pressure;
- CI=
- confidence interval;
- CVD=
- cardiovascular disease;
- DM=
- diabetes mellitus;
- FBG=
- fasting blood glucose;
- HDL-C=
- high-density lipoprotein cholesterol;
- ICH=
- intracerebral hemorrhage;
- INR=
- international normalized ratio;
- LDL-C=
- low-density lipoprotein cholesterol;
- LMIC=
- low and middle-income countries;
- NIHSS=
- NIH Stroke Scale;
- OR=
- odds ratio;
- OXVASC=
- Oxford Vascular Study;
- PAR=
- population-attributable risk;
- QVSFS=
- Questionnaire for Verifying Stroke-Free Status;
- SBP=
- systolic blood pressure;
- sICH=
- spontaneous intracerebral hemorrhage;
- SIREN=
- Stroke Investigative Research and Educational Networks;
- SMASH-U=
- structural lesions such as aneurysms/arteriovenous malformations, medication-related, amyloid angiopathy, systemic/other disease, hypertension, and undetermined causes;
- SSA=
- sub-Saharan Africa;
- TC=
- total cholesterol;
- TG=
- triglycerides;
- WHR=
- waist-to-hip ratio
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
The SIREN coinvestigators are listed in appendix 2 at the end of this article.
Editorial, page 417
- Received March 9, 2019.
- Accepted in final form September 26, 2019.
- © 2020 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Costs and Utilization of New-to-Market Neurologic Medications
Dr. Robert J. Fox and Dr. Mandy Leonard
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Location-specific risk factors for intracerebral hemorrhageSystematic review and meta-analysisWilmar M.T. Jolink, Kim Wiegertjes, Gabriël J.E. Rinkel et al.Neurology, July 20, 2020 -
Article
Cortical superficial siderosis and first-ever cerebral hemorrhage in cerebral amyloid angiopathyAndreas Charidimou, Gregoire Boulouis, Li Xiong et al.Neurology, March 29, 2017 -
Article
Cortical superficial siderosis predicts early recurrent lobar hemorrhageDuangnapa Roongpiboonsopit, Andreas Charidimou, Christopher M. William et al.Neurology, September 30, 2016 -
Articles
The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and HispanicsD. L. Labovitz, A. Halim, B. Boden-Albala et al.Neurology, August 22, 2005